Analyze Diet
Clinical and vaccine immunology : CVI2011; 18(9); 1456-1461; doi: 10.1128/CVI.05185-11

Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders.

Abstract: Glanders, caused by the Gram-negative, nonmotile bacterium Burkholderia mallei, is a contagious and highly fatal disease of equines. During the last decade, the number of glanders outbreaks has increased steadily. The disease also has high zoonotic significance and B. mallei is listed biological warfare agent. The complement fixation test (CFT) is a routinely used and internationally recognized test to screen equine sera for the glanders. However, discrepant results have been observed using the CFT. The low sensitivity and specificity of the CFT and enzyme-linked immunosorbent assay (ELISA) have been linked to the use of crude test antigens. We expressed a novel recombinant Burkholderia intracellular motility A (rBimA) protein in Escherichia coli for the diagnosis of equine glanders. Purified rBimA was used in an indirect ELISA format. All of the 21 true-positive serum samples used in the study tested positive, whereas only 17 of the 1,524 potentially negative sera tested positive by indirect ELISA, thus exhibiting 100% sensitivity and 98.88% specificity. Also, rBimA protein did not react with melioidosis patient and normal healthy human serum samples, showing its high specificity. The developed assay can be used as a simple and rapid tool for diagnosis of glanders in equine serum samples. An Indian patent (1328/DEL/2010) has been filed for the reagent.
Publication Date: 2011-07-13 PubMed ID: 21752949PubMed Central: PMC3165212DOI: 10.1128/CVI.05185-11Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Evaluation Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper details the development and validation of a novel diagnostic tool for glanders, a fatal disease caused by the bacterium Burkholderia mallei, affecting equines and also posing a risk to humans. This new tool, based on the recombinant Burkholderia intracellular motility A (rBimA) protein, exhibited a high level of sensitivity and specificity in differentiating between true positive and negative serum samples.

Context

  • The paper discusses an infectious disease known as glanders, a highly consequential infection among horses, caused by the bacterium Burkholderia mallei.
  • The infection also has significant zoonotic implications, meaning it can be transferred from animals to humans.
  • Inaccurate results with the commonly used diagnostic method, the complement fixation test (CFT), drove the researchers to explore a new avenue for diagnosing glanders.

Development of the Diagnostic Tool

  • The researchers identified the Burkholderia intracellular motility A (BimA) protein as a potential target for creating a diagnostic test. This protein was artificially recreated (recombinant), a variant named rBimA.
  • This rBimA variant was expressed in E. Coli, purified and used in a diagnostic format known as an indirect enzyme-linked immunosorbent assay (ELISA).

Validation of the Diagnostic Tool

  • The researchers then tested the performance of the rBimA-based ELISA using 21 true-positive serum samples and 1,524 possibly negative serum samples.
  • Results showed that all 21 true-positive samples tested positive, while only 17 out of the 1,524 potentially negative samples tested positive.
  • This translates to a sensitivity of 100% (ability to correctly identify positive cases) and a specificity of 98.88% (ability to correctly identify negative cases).

Conclusion and Future Applications

  • Because the rBimA protein did not react with serum from patients with melioidosis (a different disease caused by a related bacterium) or with serum from healthy individuals, the researchers believe it shows a high specificity for glanders diagnosis.
  • The developed assay can serve as a rapid and effective tool to diagnose glanders within equine serum samples, overcoming limitations of currently used tests.
  • The reagent has been filed for patent rights in India (1328/DEL/2010).

Cite This Article

APA
Kumar S, Malik P, Verma SK, Pal V, Gautam V, Mukhopadhyay C, Rai GP. (2011). Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders. Clin Vaccine Immunol, 18(9), 1456-1461. https://doi.org/10.1128/CVI.05185-11

Publication

ISSN: 1556-679X
NlmUniqueID: 101252125
Country: United States
Language: English
Volume: 18
Issue: 9
Pages: 1456-1461

Researcher Affiliations

Kumar, Subodh
  • Division of Microbiology, Defence Research and Development Establishment, Jhansi Road, Gwalior-474 002, India. subodh_kumar@email.com
Malik, Praveen
    Verma, Shailendra Kumar
      Pal, Vijai
        Gautam, Vandana
          Mukhopadhyay, Chiranjay
            Rai, Ganga Prasad

              MeSH Terms

              • Amino Acid Sequence
              • Animals
              • Antibodies, Bacterial / blood
              • Bacterial Proteins / genetics
              • Bacterial Proteins / immunology
              • Bacterial Proteins / metabolism
              • Burkholderia mallei / genetics
              • Burkholderia mallei / immunology
              • Escherichia coli / genetics
              • Escherichia coli / metabolism
              • Glanders / diagnosis
              • Glanders / immunology
              • Glanders / microbiology
              • Horse Diseases / diagnosis
              • Horse Diseases / immunology
              • Horse Diseases / microbiology
              • Horses
              • Humans
              • Microfilament Proteins / genetics
              • Microfilament Proteins / immunology
              • Microfilament Proteins / metabolism
              • Molecular Sequence Data
              • Recombinant Proteins / genetics
              • Recombinant Proteins / immunology
              • Recombinant Proteins / metabolism
              • Sensitivity and Specificity

              References

              This article includes 26 references
              1. Al-Ani F. K., Al-Rawashdeh O. F., Ali A. H., Hassan F. K.. Glanders in horses: clinical, biochemical and serological studies in Iraq. Vet. Arch. 68:155–162.
              2. Arun S.. Equine glanders in Turkey. Vet. Rec. 144:255–258.
                pubmed: 10209817
              3. Bazargani T. T., Tadjbakhs H., Badii A., Zahraei T.. The outbreak of glanders in some racehorses in three states of Iran. J. Equine Vet. Sci. 16:232–236.
              4. Boyden S. V.. Absorption by erythrocytes of antigens of Pf. mallei and Pf. whitmori. Proc. Sac. Exp. Biol. Med. 73:289.
              5. Cravitz L., Miller W. R.. Immunologic studies with Malleomyces mallei and Malleomyces pseudomallei I: serological relationships between M. mallei and M. pseudomallei. J. Infect. Dis. 86:46–51.
                pubmed: 15402290
              6. Elschner M. C.. Burkholderia mallei infection in a horse imported from Brazil. Equine Vet. Educ. 21:147–150.
              7. Elschner M. C.. Use of a Western blot technique for the serodiagnosis of glanders. BMC Vet. Res. 7:4.
                pmc: PMC3034690pubmed: 21247488
              8. Heine H. S., England M. J., Wagg D. M., Byrne W. R.. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob. Agents Chemother. 45:2119–2121.
                pmc: PMC90610pubmed: 11408233
              9. Jana A. M., Gupta A. K., Pandya G., Verma R. D., Rao K. M.. Rapid diagnosis of glanders in equines by counter-immuno-electrophoresis. Indian Vet. J. 59:5.
              10. Malik P., Khurana S. K., Dwivedi S. K.. Re-emergence of glanders in India: report of Maharashtra state. Indian J. Microbiol. 50:345–348.
                pmc: PMC3450061pubmed: 23100851
              11. Naureen A.. Antimicrobial susceptibility of 41 Burkholderia mallei isolates from spontaneous outbreaks of equine glanders in Punjab, Pakistan. J. Equine Vet. Sci. 30:134–141.
              12. Neubauer H., Meyer H., Finke E. J.. Human glanders. Rev. Int. Serv. Sante Forces Armees 70:258–265.
              13. Neubauer H.. Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. J. Vet. Med. B 52:201–205.
                pubmed: 16115091
              14. OIE. Glanders, chapter 2.5.11. Manual of diagnostic tests and vaccines for terrestrial animals 2010 OIE, Paris, France.
              15. Parthasarathy N., Deshazer D., England M., Waag D. M.. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies. Diagn. Microbiol. Infect. Dis. 56:329–332.
                pmc: PMC7127370pubmed: 16765554
              16. Sanford J. P.. Pseudomonas species (including melioidosis and glanders), p. 2003–2009 In Mandell G. L., Bennett J. E., Dolin R. (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, NY .
              17. Sen G. P., Singh G., Joshi T. P.. Comparative efficacy of serological tests in the diagnosis of glanders. Indian Vet. J. 45:286.
                pubmed: 4970533
              18. Sitthidet C.. Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J. Clin. Microbiol. 46:2418–2422.
                pmc: PMC2446894pubmed: 18495853
              19. Srinivasan A.. Glanders in a military research microbiologist. N. Engl. J. Med. 345:256–258.
                pubmed: 11474663
              20. Steele J. H.. Bacterial, rickettsial and mycotic diseases, p. 339–351 In Steele J. H. (ed.), CRC handbook series in zoonoses, section A, vol. I. CRC Press, Inc., Boca Raton, FL .
              21. Stevens J. M.. Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J. Bacteriol. 187:7857–7862.
                pmc: PMC1280302pubmed: 16267310
              22. Towbin H., Staehelin T., Gordin J.. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:4350–4354.
                pmc: PMC411572pubmed: 388439
              23. Ulrich M. P., Norwood D. A., Christensen D. R., Ulrich R. L.. Using real-time PCR to specifically detect Burkholderia mallei. J. Med. Microbiol. 55:551–559.
                pubmed: 16585642
              24. Ulrich R. L., Ulrich M. P., Schell M. A., Kim S., DeShzer D.. Development of a PCR assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae. Diagn. Microbiol. Infect. Dis. 55:47–55.
                pubmed: 16546342
              25. Verma R. D., Sharma J. K., Venkateswaran K. S., Batra H. V.. Development of an avidin-biotin dot enzyme-linked immunosorbent assay and its comparison with other serological tests for diagnosis of glanders in equines. Vet. Microbiol. 25:77–85.
                pubmed: 2247938
              26. Wheelis M.. First shots fired in biological warfare. Nature 395:213.
                pubmed: 9751039